• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOYA SURGICAL OPTICS, INC. 255; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOYA SURGICAL OPTICS, INC. 255; INTRAOCULAR LENS Back to Search Results
Model Number 255 (+19.50 D)
Device Problem Material Split, Cut or Torn (4008)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/01/2022
Event Type  malfunction  
Event Description
Damaged haptic after implantation.The iol remained in the eye though the trailing haptic was separated.The haptic piece remained in the injector.The patient's health was not impacted for now.
 
Manufacturer Narrative
This initial report is being submitted to fda for a reportable event that occurred outside the usa.Haptic damage is indicated as a potential malfunction related to the iol, as covered under the warnings section of the product's instructions for use (ifu).Regarding investigation summary- manufacturer's codes for: type of investigation, findings, and conclusion are pending the completion of the product investigation.Once the product investigation is completed, a follow-up report will be submitted to fda which will include the manufacturer's codes for type of investigation, findings, and conclusion.
 
Manufacturer Narrative
This follow-up #1 emdr is being submitted to fda for a reportable event that occurred outside of the usa.The report includes corrected information and additional information not available/included in the initial report.Corrected information: d9 - corrected to yes h3 - corrected to yes additional information: d9 - added date returned g6 - type of report - noted as follow-up #1 h2 - type of follow-up - noted for corrected information and additional information h6 - added codes for manufacturer's investigation: type; findings; and conclusion.Portions of the product were returned to the manufacturer.The investigation was conducted, with the methods and results as noted below.The haptic piece was not released into the eye.In the returned injector, the haptic piece was found between the nozzle and rod.No abnormalities were found in production and inspection records of the product.(serial no.: (b)(6).Model: 255).Dye test and release test results showed the tip was properly coated.Proper coating allows the lens to advance.Exact root cause was not determined.However, based on the available information and our investigation, we believe this event was not caused by our product quality.Capa-22-0009 has been initiated for "damaged haptic" complaints.
 
Event Description
Damaged haptic after implantation.The iol remained in the eye though the trailing haptic was separated.The haptic piece remained in the injector.The patient's health was not impacted for now.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
255
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
HOYA SURGICAL OPTICS, INC.
525 technology drive
suite 280
irvine CA 92618
Manufacturer (Section G)
HOYA CORPORATION
6-10-1 nishi shinjuku
shinjuku-ku
tokyo, 160-0 023
JA   160-0023
Manufacturer Contact
goutham pendyala
525 technology drive
suite 280
irvine, CA 92618
9093896317
MDR Report Key16030948
MDR Text Key308172092
Report Number3006723646-2022-00163
Device Sequence Number1
Product Code HQL
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P080004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 12/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number255 (+19.50 D)
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 12/01/2022
Initial Date FDA Received12/21/2022
Supplement Dates Manufacturer Received12/01/2022
Supplement Dates FDA Received01/08/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/30/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-